Jump Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Sell
81,441
-108,559
-57% -$333K ﹤0.01% 2051
2026
Q2
$578K Buy
+190,000
New +$567K ﹤0.01% 1407
2026
Q1
– Sell
-242,017
Closed -$874K – 1847
2025
Q4
$874K Buy
242,017
+126,217
+109% +$550K 0.01% 1033
2025
Q3
$437K Buy
+115,800
New +$447K 0.01% 1352
2024
Q3
– Sell
-281,000
Closed -$1.87M – 1609
2024
Q2
$1.87M Buy
281,000
+194,812
+226% +$1.44M 0.04% 581
2024
Q1
$877K Buy
86,188
+75,528
+709% +$768K 0.02% 873
2023
Q4
$120K Buy
+10,660
New +$44.5K ﹤0.01% 1643
2023
Q3
– Sell
-21,249
Closed -$75K – 1813
2023
Q2
$75K Sell
21,249
-267,451
-93% -$1.2M ﹤0.01% 1690
2023
Q1
$1.22M Buy
+288,700
New +$3.43M 0.05% 530
2022
Q2
– Sell
-10,200
Closed -$62K – 1584
2022
Q1
$62K Sell
10,200
-35,200
-78% -$259K ﹤0.01% 1455
2021
Q4
$416K Buy
+45,400
New +$482K 0.03% 737
2021
Q2
– Sell
-52,651
Closed -$744K – 1054
2021
Q1
$744K Buy
52,651
+15,951
+43% +$258K 0.07% 301
2020
Q4
$414K Sell
36,700
-19,900
-35% -$234K 0.07% 452
2020
Q3
$747K Buy
+56,600
New +$1.13M 0.15% 212

Other funds holding ALT

Jump Financial's ALT Position: Q3 2026 in Review

Jump Financial reduced its Altimmune (ALT) stake by 57% in Q3 2026, selling an estimated $333K and leaving 81,441 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Jump Financial first reported a position in ALT in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.87M in Q2 2024. 190 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Jump Financial held 81,441 shares of Altimmune worth $233K as of Q3 2026.
  • Jump Financial sold 108,559 Altimmune shares in Q3 2026, an estimated $333K.
  • Altimmune made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2051 holding.
  • Jump Financial first reported a position in Altimmune in Q3 2020 and has held it in 14 quarters since.
  • Jump Financial's Altimmune position peaked at $1.87M in Q2 2024.
  • 190 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.